However, the biological function of ERBB4 and its potential as a cancer drug target have not been explicitly described, and we also hope that patients suffering from TNBC with ERBB4 overexpression would benefit from further clinical trials on receptor tyrosine kinase (RTKs). The gene discussed is NTRK1; the disease is cancer.